Pediatric Infectious Diseases And Emerging Challenges In Prevention And Management Strategies Worldwide

Abstract

Background: Infectious diseases remain one of the major causes of ill-health and death globally, especially in developing nations. Despite immunisation and treatment interventions, childhood infectious diseases (e.g. pneumonia, diarrhoea, malaria) remain a major cause of disease, affecting around 5 million young children (aged under five) and causing death every year. Objective: The purpose of this study is to review the current and new challenges in the prevention and treatment of pediatric infectious diseases, with particular regard to increasing antibiotic resistance, vaccine coverage, and new emerging pathogens. Method: This study included an organized review of international epidemiological and clinical research between 2015 and 2025. We have analysed global health databases and peer-reviewed journals to assess changes in disease burden, preventive measures and treatment effectiveness. Results: The study shows a rise of 20-30% in the resistance of common childhood infections to antibiotics, diminishing efficacy of treatment. Vaccine rates up to 15% lower in some regions also explain the reappearance of vaccine-preventable diseases. The emergence of new infections and climate-sensitive diseases add to complexity. Conclusion: Child infectious diseases remain a major challenge. Improving integrated prevention strategies, vaccination coverage, and reducing antibiotic resistance are key to decreasing burden and enhancing good health outcomes in children.